Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Bolni Nagalo

Concepts (213)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Blood Donors
11
2021
31
3.900
Why?
Hepatitis B
8
2023
23
2.090
Why?
Oncolytic Virotherapy
3
2022
18
1.670
Why?
HIV Infections
11
2021
356
1.570
Why?
Hepatitis B Surface Antigens
4
2018
9
1.510
Why?
Syphilis
7
2019
27
1.310
Why?
Liver Neoplasms
6
2025
331
1.280
Why?
Carcinoma, Hepatocellular
5
2025
196
1.200
Why?
Blood Transfusion
3
2021
127
1.130
Why?
Hepatitis C
5
2021
81
1.120
Why?
Seroepidemiologic Studies
10
2021
51
0.900
Why?
Burkina Faso
16
2023
16
0.880
Why?
Vesicular Stomatitis
1
2022
1
0.820
Why?
Enzyme-Linked Immunosorbent Assay
4
2018
234
0.750
Why?
Biliary Tract Neoplasms
4
2022
9
0.730
Why?
HIV Antibodies
1
2018
10
0.640
Why?
Blood-Borne Pathogens
1
2018
7
0.630
Why?
HIV-1
4
2018
53
0.580
Why?
Gabon
4
2019
4
0.510
Why?
Mass Screening
1
2018
348
0.500
Why?
Hepatitis B virus
3
2025
26
0.450
Why?
Rural Population
1
2018
551
0.450
Why?
Young Adult
11
2021
4052
0.440
Why?
Skin Neoplasms
3
2024
487
0.430
Why?
Humans
37
2025
50201
0.430
Why?
HIV Seroprevalence
2
2014
4
0.420
Why?
Vesiculovirus
2
2022
6
0.420
Why?
Bile Duct Neoplasms
2
2022
28
0.390
Why?
Cholangiocarcinoma
2
2022
26
0.390
Why?
Adult
17
2025
13486
0.380
Why?
Adolescent
10
2021
6459
0.380
Why?
Antibodies, Viral
1
2011
94
0.380
Why?
Plasma
1
2011
42
0.370
Why?
Communicable Diseases
1
2011
52
0.370
Why?
Polymorphism, Single Nucleotide
2
2025
484
0.330
Why?
Melanoma
2
2024
281
0.320
Why?
Middle Aged
13
2025
12356
0.290
Why?
Female
18
2025
26829
0.290
Why?
Prevalence
6
2018
960
0.280
Why?
Male
15
2025
25572
0.280
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2022
1000
0.270
Why?
Cell Line, Tumor
4
2024
1390
0.270
Why?
Antineoplastic Agents
3
2024
1176
0.260
Why?
Sensitivity and Specificity
2
2018
871
0.260
Why?
Hepacivirus
2
2018
105
0.250
Why?
Cell Proliferation
4
2024
987
0.240
Why?
Extracellular Matrix Proteins
1
2025
69
0.240
Why?
Molecular Docking Simulation
2
2023
72
0.240
Why?
Monophenol Monooxygenase
1
2023
5
0.230
Why?
Animals
7
2024
13141
0.230
Why?
Incidence
2
2021
1000
0.220
Why?
Carcinoma, Pancreatic Ductal
1
2024
32
0.220
Why?
Anti-HIV Agents
2
2014
42
0.220
Why?
Drug Synergism
2
2021
152
0.220
Why?
Doxorubicin
1
2024
234
0.210
Why?
Psoriasis
1
2023
29
0.210
Why?
Dermatitis
1
2023
36
0.210
Why?
Vesicular stomatitis Indiana virus
1
2022
4
0.210
Why?
Antioxidants
2
2023
237
0.200
Why?
Mice
5
2024
5673
0.200
Why?
Students, Medical
1
2023
159
0.190
Why?
Pancreatic Neoplasms
1
2024
209
0.190
Why?
Treponema pallidum
2
2018
10
0.190
Why?
Flavonols
1
2020
2
0.190
Why?
Risk Factors
4
2020
3644
0.180
Why?
Viral Proteins
1
2022
156
0.180
Why?
Disease Models, Animal
2
2023
1419
0.180
Why?
Cymbopogon
1
2020
1
0.180
Why?
Oils, Volatile
1
2020
12
0.180
Why?
Immunotherapy
2
2021
235
0.170
Why?
Protein Kinase Inhibitors
1
2021
205
0.170
Why?
Receptors, KIR
1
2019
13
0.170
Why?
Sequence Deletion
1
2020
69
0.170
Why?
Plasma Membrane Calcium-Transporting ATPases
1
2019
2
0.170
Why?
Genotype
4
2025
542
0.170
Why?
Glutathione Transferase
1
2020
173
0.160
Why?
Polymorphism, Genetic
1
2020
181
0.160
Why?
Retrospective Studies
6
2022
6190
0.160
Why?
Gene Frequency
3
2025
96
0.160
Why?
Virology
1
2018
6
0.160
Why?
Genetic Predisposition to Disease
4
2025
508
0.160
Why?
Anti-Inflammatory Agents
1
2020
162
0.160
Why?
HIV
1
2018
25
0.160
Why?
Aged
6
2022
9505
0.150
Why?
Molecular Structure
3
2024
293
0.150
Why?
Case-Control Studies
4
2025
1145
0.150
Why?
Immunotherapy, Adoptive
1
2018
159
0.140
Why?
Blood Pressure
1
2019
527
0.140
Why?
Odds Ratio
1
2018
548
0.130
Why?
T-Lymphocytes
1
2018
329
0.130
Why?
Polymerase Chain Reaction
2
2014
456
0.130
Why?
Cross-Sectional Studies
2
2018
1580
0.130
Why?
Cisplatin
3
2022
275
0.120
Why?
HIV-2
1
2014
1
0.120
Why?
Hospitals, Military
1
2014
7
0.120
Why?
Time Factors
2
2018
2909
0.120
Why?
Drug Monitoring
1
2014
78
0.120
Why?
Antibodies, Monoclonal
1
2018
459
0.120
Why?
Syphilis Serodiagnosis
1
2014
4
0.120
Why?
RNA, Viral
2
2014
124
0.120
Why?
Peritonitis
1
2014
27
0.110
Why?
Community-Acquired Infections
1
2014
39
0.110
Why?
Immunocompromised Host
1
2014
119
0.110
Why?
Viremia
1
2014
22
0.110
Why?
Neoplasms
1
2023
1233
0.110
Why?
Alleles
2
2025
253
0.110
Why?
Meningitis, Bacterial
1
2013
6
0.110
Why?
Infectious Disease Transmission, Vertical
1
2012
15
0.110
Why?
Rubella
1
2012
4
0.100
Why?
Antiretroviral Therapy, Highly Active
1
2012
33
0.100
Why?
Toxoplasmosis
1
2012
15
0.100
Why?
Antibodies, Protozoan
1
2012
12
0.100
Why?
Bacteria
1
2014
220
0.100
Why?
Bile Ducts, Intrahepatic
2
2022
15
0.100
Why?
Real-Time Polymerase Chain Reaction
1
2013
181
0.100
Why?
Pilot Projects
2
2013
703
0.100
Why?
Drug Screening Assays, Antitumor
2
2024
131
0.100
Why?
Apoptosis
3
2024
1093
0.100
Why?
TOR Serine-Threonine Kinases
2
2023
77
0.100
Why?
Liver Cirrhosis
2
2025
228
0.100
Why?
Pregnancy Complications, Infectious
1
2012
76
0.090
Why?
Structure-Activity Relationship
2
2024
394
0.090
Why?
Deoxycytidine
2
2021
28
0.090
Why?
Hospitals, Teaching
1
2011
53
0.090
Why?
Autophagy
2
2023
167
0.090
Why?
Tumor Microenvironment
2
2024
222
0.090
Why?
Xenograft Model Antitumor Assays
2
2021
212
0.090
Why?
Cohort Studies
2
2025
1414
0.080
Why?
Programmed Cell Death 1 Receptor
2
2021
40
0.080
Why?
Tumor Cells, Cultured
2
2020
462
0.080
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2011
579
0.080
Why?
Prospective Studies
2
2012
2396
0.080
Why?
Anti-Bacterial Agents
1
2014
744
0.080
Why?
Hepatitis B, Chronic
1
2025
17
0.060
Why?
Ionic Liquids
1
2024
1
0.060
Why?
Ablation Techniques
1
2024
22
0.060
Why?
Hydrogels
1
2024
17
0.060
Why?
Delayed-Action Preparations
1
2024
55
0.060
Why?
rho-Associated Kinases
1
2024
20
0.060
Why?
Hedgehog Proteins
1
2024
33
0.060
Why?
Blood Banks
2
2014
18
0.060
Why?
Azoles
1
2023
28
0.060
Why?
Immunomodulation
1
2024
37
0.060
Why?
Rabbits
1
2024
376
0.060
Why?
HLA-DRB1 Chains
1
2023
5
0.050
Why?
Research
1
2023
107
0.050
Why?
HLA Antigens
1
2023
53
0.050
Why?
Interleukin-17
1
2023
37
0.050
Why?
Medical Oncology
1
2023
96
0.050
Why?
Computer Simulation
1
2023
281
0.050
Why?
Pyrazoles
1
2023
111
0.050
Why?
Sirolimus
1
2023
62
0.050
Why?
Platinum
1
2022
11
0.050
Why?
Clone Cells
1
2022
78
0.050
Why?
Proto-Oncogene Proteins c-akt
1
2023
155
0.050
Why?
Phosphatidylinositol 3-Kinases
1
2023
139
0.050
Why?
Cyclin-Dependent Kinase 6
1
2021
2
0.050
Why?
Cyclin-Dependent Kinase 4
1
2021
11
0.050
Why?
Program Evaluation
1
2023
347
0.050
Why?
Receptor, Fibroblast Growth Factor, Type 2
1
2021
11
0.050
Why?
Pregnancy
3
2014
2609
0.050
Why?
Enzyme Inhibitors
1
2023
378
0.050
Why?
Cyclin-Dependent Kinase 2
1
2020
13
0.050
Why?
Proto-Oncogene Proteins c-kit
1
2020
36
0.050
Why?
Curriculum
1
2023
397
0.040
Why?
Cytidine Monophosphate
1
2020
1
0.040
Why?
Flame Ionization
1
2020
3
0.040
Why?
Medicine, Traditional
1
2020
18
0.040
Why?
Mice, Inbred NOD
1
2020
94
0.040
Why?
Plant Leaves
1
2020
40
0.040
Why?
Gas Chromatography-Mass Spectrometry
1
2020
66
0.040
Why?
Mice, SCID
1
2020
173
0.040
Why?
Aldehydes
1
2020
82
0.040
Why?
Cytokines
1
2023
607
0.040
Why?
Genomics
1
2021
284
0.040
Why?
Lipids
1
2020
147
0.040
Why?
DNA, Viral
1
2019
133
0.040
Why?
Sesquiterpenes
1
2020
88
0.040
Why?
Cell Survival
1
2020
590
0.040
Why?
Immunohistochemistry
1
2021
973
0.040
Why?
Genetic Association Studies
1
2019
115
0.040
Why?
CTLA-4 Antigen
1
2018
23
0.040
Why?
Inflammation
1
2023
608
0.040
Why?
Alcohol Drinking
1
2020
221
0.040
Why?
Rats
1
2024
3277
0.040
Why?
Neoplasm Recurrence, Local
1
2021
630
0.040
Why?
Dose-Response Relationship, Drug
1
2020
1356
0.040
Why?
Signal Transduction
1
2024
1612
0.030
Why?
Body Mass Index
1
2020
658
0.030
Why?
Phenotype
1
2019
732
0.030
Why?
Smoking
1
2020
506
0.030
Why?
CD4 Lymphocyte Count
1
2014
32
0.030
Why?
Aged, 80 and over
1
2022
3158
0.030
Why?
Risk Assessment
1
2019
1255
0.030
Why?
Opportunistic Infections
1
2014
58
0.030
Why?
Reagent Kits, Diagnostic
1
2014
18
0.030
Why?
Genotyping Techniques
1
2014
20
0.030
Why?
Hepatitis C Antibodies
1
2014
20
0.030
Why?
Donor Selection
1
2014
12
0.030
Why?
Drug Resistance, Bacterial
1
2014
73
0.030
Why?
Drug Therapy, Combination
1
2014
382
0.030
Why?
Weight Gain
1
2014
234
0.030
Why?
Microbial Sensitivity Tests
1
2014
272
0.030
Why?
Pregnancy Complications, Parasitic
1
2012
4
0.030
Why?
Antibodies, Anti-Idiotypic
1
2012
19
0.030
Why?
Molecular Diagnostic Techniques
1
2013
33
0.030
Why?
Water
1
2012
75
0.030
Why?
Disease Progression
1
2014
821
0.020
Why?
Comorbidity
1
2014
612
0.020
Why?
Socioeconomic Factors
1
2012
584
0.020
Why?
Follow-Up Studies
1
2014
2188
0.020
Why?
Treatment Outcome
1
2014
5203
0.010
Why?
Child
1
2012
6862
0.010
Why?
Nagalo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description